BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3493786)

  • 1. Surface marker expression of human B-cell lymphomas.
    Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies.
    Kokai Y; Ishii Y; Kikuchi K
    Clin Exp Immunol; 1986 May; 64(2):382-91. PubMed ID: 3527505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.
    Ishii Y; Takami T; Yuasa H; Takei T; Kikuchi K
    Clin Exp Immunol; 1984 Oct; 58(1):183-92. PubMed ID: 6332692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
    Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
    J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies.
    Takami T; Ishii Y; Yuasa H; Kikuchi K
    J Immunol; 1985 Feb; 134(2):828-34. PubMed ID: 3917477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human B-lymphocyte antigen shared with lymphoid dendritic cells: characterization by monoclonal antibody.
    Ishii Y; Takami T; Kokai Y; Yuasa H; Fujimoto J; Takei T; Kikuchi K
    Clin Exp Immunol; 1985 Sep; 61(3):624-32. PubMed ID: 3907905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
    Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
    Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an early activation antigen (Bac-1) on human B cells.
    Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
    J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B5, a new B cell-restricted activation antigen.
    Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
    Armitage RJ; Cawley JC
    Clin Exp Immunol; 1986 Feb; 63(2):298-302. PubMed ID: 3009062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigens on human plasma cells identified by monoclonal antibodies.
    Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
    J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells.
    Anderson KC; Roach JA; Daley JF; Schlossman SF; Nadler LM
    J Immunol; 1986 May; 136(10):3612-8. PubMed ID: 3084636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
    Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
    J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma.
    Aida Y; Okada K; Amanuma H
    Cancer Res; 1993 Jan; 53(2):429-37. PubMed ID: 8380256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.